Drug
Sulbactam clinical trials
- studies test it
- 18
- open now
- 5
- in phase 3
- 3
- first study started
- 2003
Keep track of what changes. Save the Sulbactam studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2003 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 2003 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 1
- Phase 3
- 3
- Phase 4
- 11
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 9
Xiangbei Welman Pharmaceutical Co., Ltd (3) · Entasis Therapeutics (2) · Pfizer (2) · Yuzuncu Yil University (1) · Sutep Jaruratanasirikul (1) · Medical University of Vienna (1) · Marmara University (1) · The University of Queensland (1)
Often tested with
Tested in the same studies.
Ampicillin (8) · Ceftriaxone (5) · Amoxicillin (3) · Azithromycin (2) · Durlobactam (2) · Tigecycline (2) · Clindamycin (2) · Fosfomycin (2)
Studies
Open first, then newest update. How each study uses Sulbactam is read from its arms, and is right about nine times in ten.
Testing it · 18
- A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex InfectionRecruitingPhase 1Innoviva Specialty TherapeuticsNCT06801223Written as Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours)
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform TrialNot yet recruitingPhase 2The University of QueenslandNCT07485010Written as Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours)
- Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAPRecruitingPhase 4Medical College of WisconsinNCT06494072Written as Ampicillin / Sulbactam Injection
- Therapeutic Options for CRABRecruitingPhase 4Clinical Hospital Centre ZagrebNCT06440304Written as ampicillin/sulbactam
- Optimising TREATment for Severe Gram-Negative Bacterial InfectionsRecruitingPhase 4National University of SingaporeNCT07004049Written as Colistin/Polymyxin B + Sulbactam
- Effects of Different Antibiotic Regimens in Preterm Premature Rupture of MembranesCompletedNot applicableYuzuncu Yil UniversityNCT07148622Written as Antibiotic regimen 1: sulbactam + ampicillin + azithromycin
- Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus ComplexCompletedPhase 3Entasis TherapeuticsNCT03894046Written as Sulbactam
- Evaluate Bioequivalence of Burotam (1/1 g/Vial)Status unknownPhase 4Yung Shin Pharm. Ind. Co., Ltd.NCT05654090Written as cefoperazone sodium and sulbactam sodium
- Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial RegimensTerminatedPhase 4Mercy Health OhioNCT03560232Written as Ampicillin/sulbactam
- A Study Evaluating Efficacy and Safety of CRO-SBT in the Treatment of GonorrheaCompletedPhase 4Xiangbei Welman Pharmaceutical Co., LtdNCT04202068Written as Ceftriaxone sodium and Sulbactam Sodium for injection
- PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT)CompletedPhase 4Xiangbei Welman Pharmaceutical Co., LtdNCT04066621Written as Ceftriaxone Sodium and Sulbactam Sodium for Injection
- Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System InfectionCompletedPhase 4Xiangbei Welman Pharmaceutical Co., LtdNCT01760109Written as Piperacillin Sodium and Sulbactam Sodium
- Study to Determine and Compare Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam in Healthy SubjectsCompletedPhase 1Entasis TherapeuticsNCT03303924Written as ETX2514 and sulbactam
- Pharmacodynamics Modeling to Optimize Dosage Regimens of Sulbactam in Patients With Acinetobacter InfectionsCompletedPhase 4Sutep JaruratanasirikulNCT02688322Written as Sulbactam
- Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy PatientsCompletedPhase 3Medical University of ViennaNCT02007603Written as Ampicillin / sulbactam
- The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients.CompletedPhase 4Marmara UniversityNCT00356148Written as Ampicillin/Sulbactam
- The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)CompletedPhase 3PfizerNCT01189487Written as ampicillin sodium/sulbactam sodium
- Zithromax EV in Community-Acquired Pneumonia (CAP)CompletedPhase 4PfizerNCT00137007Written as Ampicillin/sulbactam
Given in every arm · 1 — Sulbactam is usual care beside what is tested
As the comparator · 3 — what is tested is compared with Sulbactam
- Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract InfectionSuspendedPhase 2Xiangbei Welman Pharmaceutical Co., LtdNCT01601093Written as Cefoperazone and Sulbactam Sodium (CFP/SUB)
- A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal InfectionsCompletedPhase 4Kaohsiung Medical University Chung-Ho Memorial HospitalNCT00952796Written as ampicillin/sulbactam
- BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration PneumoniaCompletedPhase 3BayerNCT01045902Written as Sulbactam/Ampicillin
Codes
What other systems call Sulbactam · ClinicalTrials.gg INT008247
- MeSH (NLM) D013407SulbactamConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) S4TF6I2330SULBACTAMConfirmed FDA, NLM, Wikidata
- RxNorm 10167Confirmed FDA, Wikidata
- Wikidata Q423393sulbactamConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61957SulbactamOne source FDA
- DrugBank DB09324One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D013407 | Sulbactam | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | S4TF6I2330 | SULBACTAM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 10167 | — | Confirmed FDA, Wikidata |
| Wikidata | Q423393 | sulbactam | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61957 | Sulbactam | One source FDA |
| DrugBank | DB09324 | — | One source Wikidata |
Also registered as sulbactam sodium (UNII DKQ4T82YE6 · RxNorm 82100).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.